CME Group (NASDAQ:CME) Given New $200.00 Price Target at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME) had its target price raised by Deutsche Bank Aktiengesellschaft from $193.00 to $200.00 in a report published on Thursday, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the financial services provider’s stock.

A number of other research analysts also recently commented on the stock. Bank of America increased their price target on shares of CME Group from $209.00 to $216.00 and gave the company a neutral rating in a report on Thursday, April 25th. Barclays raised their price objective on shares of CME Group from $208.00 to $209.00 and gave the stock an equal weight rating in a research note on Thursday, July 25th. Piper Sandler decreased their price objective on shares of CME Group from $235.00 to $225.00 and set an overweight rating for the company in a research note on Thursday, July 25th. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an underweight rating in a research note on Thursday, July 25th. Finally, Rosenblatt Securities reissued a sell rating and issued a $187.00 price objective (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Three investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $213.27.

CME Group Trading Up 1.5 %

Shares of NASDAQ:CME traded up $3.18 during trading on Thursday, reaching $208.47. The company’s stock had a trading volume of 428,113 shares, compared to its average volume of 1,943,036. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group has a 12 month low of $190.70 and a 12 month high of $223.80. The firm’s 50 day simple moving average is $198.36 and its two-hundred day simple moving average is $207.02. The stock has a market capitalization of $75.06 billion, a PE ratio of 23.64, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter last year, the firm earned $2.30 EPS. The firm’s revenue for the quarter was up 12.7% compared to the same quarter last year. On average, research analysts predict that CME Group will post 9.8 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.21%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insider Activity at CME Group

In related news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the transaction, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Elizabeth A. Cook sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $211.52, for a total transaction of $211,520.00. Following the completion of the sale, the director now owns 18,241 shares of the company’s stock, valued at $3,858,336.32. The disclosure for this sale can be found here. Insiders have sold a total of 4,650 shares of company stock valued at $928,776 over the last ninety days. 0.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On CME Group

Several institutional investors have recently bought and sold shares of CME. B. Riley Wealth Advisors Inc. lifted its stake in shares of CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares during the period. Capital Advisors Ltd. LLC lifted its stake in shares of CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the period. Lantz Financial LLC lifted its stake in shares of CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after buying an additional 49 shares during the period. Transcend Capital Advisors LLC lifted its stake in shares of CME Group by 1.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after buying an additional 50 shares during the period. Finally, Lester Murray Antman dba SimplyRich lifted its stake in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.